Targeting B-cell maturation antigen increases sensitivity of multiple myeloma cells to MCL-1 inhibition

Haematologica. 2022 Apr 1;107(4):980-983. doi: 10.3324/haematol.2021.279517.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Cell Maturation Antigen*
  • Cell Line, Tumor
  • Humans
  • Multiple Myeloma* / drug therapy
  • Myeloid Cell Leukemia Sequence 1 Protein / genetics
  • Proto-Oncogene Proteins c-bcl-2

Substances

  • B-Cell Maturation Antigen
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Proto-Oncogene Proteins c-bcl-2